Literature DB >> 33516274

Genetic and molecular biology of systemic lupus erythematosus among Iranian patients: an overview.

Meisam Gachpazan1, Iman Akhlaghipour2, Hamid Reza Rahimi1, Ehsan Saburi1, Majid Mojarrad1, Mohammad Reza Abbaszadegan1, Meysam Moghbeli3.   

Abstract

BACKGROUND: Systemic lupus erythematosus (SLE) is a clinicopathologically heterogeneous chronic autoimmune disorder affecting different organs and tissues. It has been reported that there is an increasing rate of SLE incidence among Iranian population. Moreover, the Iranian SLE patients have more severe clinical manifestations compared with other countries. Therefore, it is required to introduce novel methods for the early detection of SLE in this population. Various environmental and genetic factors are involved in SLE progression. MAIN BODY: In present review we have summarized all of the reported genes which have been associated with clinicopathological features of SLE among Iranian patients.
CONCLUSIONS: Apart from the reported cytokines and chemokines, it was interestingly observed that the apoptosis related genes and non-coding RNAs were the most reported genetic abnormalities associated with SLE progression among Iranians. This review clarifies the genetics and molecular biology of SLE progression among Iranian cases. Moreover, this review paves the way of introducing an efficient panel of genetic markers for the early detection and better management of SLE in this population.

Entities:  

Keywords:  Diagnosis; Genetic; Iran; Marker; Systemic lupus erythematosus

Year:  2021        PMID: 33516274      PMCID: PMC7847600          DOI: 10.1186/s13317-020-00144-y

Source DB:  PubMed          Journal:  Auto Immun Highlights        ISSN: 2038-0305


  211 in total

1.  B7S1, a novel B7 family member that negatively regulates T cell activation.

Authors:  Durbaka V R Prasad; Sabrina Richards; Xoi Muoi Mai; Chen Dong
Journal:  Immunity       Date:  2003-06       Impact factor: 31.745

2.  Association between 318C/T polymorphism of the CTLA-4 gene and systemic lupus erythematosus in Iranian patients.

Authors:  Mahdieh Shojaa; Mehrdad Aghaie; Mahsa Amoli; Naemeh Javid; Fatemeh Shakeri; Patricia Khashayar; Alijan Tabarraei; Abbas A Keshtkar; Hamid R Joshaghani; Arghavan Kouroshnia; Mostafa Qorbani; Faranak Mahmoudi; Ramin Mohebbi; Neda Ranjbarpour
Journal:  Int J Rheum Dis       Date:  2014-01-09       Impact factor: 2.454

Review 3.  The IL-4 receptor: signaling mechanisms and biologic functions.

Authors:  K Nelms; A D Keegan; J Zamorano; J J Ryan; W E Paul
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

Review 4.  The Yin and Yang of HLA and KIR in human disease.

Authors:  Smita Kulkarni; Maureen P Martin; Mary Carrington
Journal:  Semin Immunol       Date:  2008-07-16       Impact factor: 11.130

5.  Early target genes of IL-12 and STAT4 signaling in th cells.

Authors:  Riikka J Lund; Zhi Chen; Joonas Scheinin; Riitta Lahesmaa
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

6.  Evaluation of PBMC Distribution and TLR9 Expression in Patients with Systemic Lupus Erythematosus.

Authors:  Sahar Mortezagholi; Zohreh Babaloo; Parisa Rahimzadeh; Mojgan Ghaedi; Hayedeh Namdari; Shirin Assar; Maryam Azimi Mohamadabadi; Eisa Salehi
Journal:  Iran J Allergy Asthma Immunol       Date:  2016-06       Impact factor: 1.464

7.  Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule.

Authors:  J Cheng; T Zhou; C Liu; J P Shapiro; M J Brauer; M C Kiefer; P J Barr; J D Mountz
Journal:  Science       Date:  1994-03-25       Impact factor: 47.728

8.  Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo.

Authors:  Phyllis-Jean Linton; Beverly Bautista; Elana Biederman; Evan S Bradley; Judith Harbertson; Robyn M Kondrack; Ryan C Padrick; Linda M Bradley
Journal:  J Exp Med       Date:  2003-03-31       Impact factor: 14.307

9.  Common variants within MECP2 confer risk of systemic lupus erythematosus.

Authors:  Amr H Sawalha; Ryan Webb; Shizhong Han; Jennifer A Kelly; Kenneth M Kaufman; Robert P Kimberly; Marta E Alarcón-Riquelme; Judith A James; Timothy J Vyse; Gary S Gilkeson; Chan-Bum Choi; R Hal Scofield; Sang-Cheol Bae; Swapan K Nath; John B Harley
Journal:  PLoS One       Date:  2008-03-05       Impact factor: 3.240

10.  Association of FAS and FAS ligand genes polymorphism and risk of systemic lupus erythematosus.

Authors:  Bita Moudi; Saeedeh Salimi; Farzaneh Farajian Mashhadi; Mahnaz Sandoughi; Zahra Zakeri
Journal:  ScientificWorldJournal       Date:  2013-11-14
View more
  1 in total

1.  Prognostic Impact of Genetic Variants of MECP2 and TIRAP on Clinical Outcomes of Systemic Lupus Erythematosus with and without Nephritis.

Authors:  Safaa I Tayel; Nashwa M Muharram; Dina S Fotoh; Hany S Elbarbary; Huda I Abd-Elhafiz; Eman A El-Masry; Ahmed E Taha; Shimaa E Soliman
Journal:  Biomolecules       Date:  2021-09-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.